DIFFERENTIAL BINDING OF PR3 AND MPO TO MONOLAYERS OF HUVEC - ANCA MEDIATED ADCC OF PR3/MPO INCUBATED HUVEC

DIFFERENTIAL BINDING OF PR3 AND MPO TO MONOLAYERS OF HUVEC - ANCA MEDIATED ADCC OF PR3/MPO INCUBATED HUVEC

Bibliographic Details
Main Authors:	Ballieux, B, Zondervan, K, Kievit, P, Hagen, E, Vanderwoude, F, Vanes, L, Daha, M
Format:	Journal article
Published:	1994

Similar Items

Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis
by: Samy Hakroush, et al.
Published: (2021-10-01)

Binding of proteinase 3 and myeloperoxidase to endothelial cells: ANCA-mediated endothelial damage through ADCC?
by: Ballieux, B, et al.
Published: (1994)

PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA disease
by: Dhruti P. Chen, et al.
Published: (2023-02-01)

Pyoderma gangrenosum–like facial ulcers in a woman associated with cocaine use and cANCA/anti-PR3+, pANCA/anti-MPO– serology
by: Jeffrey D. McBride, MD, PhD, et al.
Published: (2020-09-01)

Presentation and progression of MPO-ANCA interstitial lung disease
by: Lorenzo Salvati, et al.
Published: (2024-06-01)

Multiple Myeloma Presenting as MPO-ANCA Associated Microscopic Polyangiitis
by: S. Kapoulas, et al.
Published: (2005-09-01)

Case Report of Atypical Course of MPO-ANCA Associated Vasculitis
by: O.R. Boiarchuk, et al.
Published: (2014-11-01)

MPO-ANCA associated vasculitis with mononeuritis multiplex following influenza vaccination
by: Stefanie Eindhoven, et al.
Published: (2017-12-01)

Detección de anticuerpos contra los antígenos de diferenciación tumoral proteinasa 3 (PR3) y mieloperoxidasa (MPO) en la leucemia promielocítica Detection of antibodies to antigens of proteinase 3 (PR3) tumor differentiations and myeloperoxidase (MPO) in cases of promyelocytic leukemia
by: Ada A. Arce Hernández, et al.
Published: (2010-08-01)

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia: PR3-versus MPO-ANCA-associated vasculitis, an exploratory cross-sectional studyResearch in context
by: Charmaine van Eeden, et al.
Published: (2023-04-01)

Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients
by: Xueling Hu, et al.
Published: (2022-10-01)

MPO-ANCA associated crescentic glomerulonephritis with numerous immune complexes: case report
by: Morizane Ryuji, et al.
Published: (2012-06-01)

Dual-Positive MPO- and PR3-ANCA-Associated Vasculitis Following SARS-CoV-2 mRNA Booster Vaccination: A Case Report and Systematic Review
by: Eva Baier, et al.
Published: (2022-04-01)

Contribution of Reflex MPO/PR3 Testing in Anti-neutrophil Cytoplasmic Auto-Antibodies Positive Sera: An Indian Perspective
by: Nividha Fernandes, et al.
Published: (2016-07-01)

MPO-ANCA Associated Vasculitis Following COVID-19 Vaccination – A Case Report
by: Mahmoud Khalifa, et al.
Published: (2021-05-01)

Neutrophil Extracellular Traps: A Potential Therapeutic Target in MPO-ANCA Associated Vasculitis?
by: Kim M. O'Sullivan, et al.
Published: (2021-03-01)

Reversible Sensorineural Hearing Loss due to Pachymeningitis Associated with Elevated Serum MPO-ANCA
by: Eun-Jung Lim, et al.
Published: (2011-09-01)

MPO-ANCA-associated necrotizing glomerulonephritis in rheumatoid arthritis; a case report and review of literature
by: Mário Góis, et al.
Published: (2017-04-01)

Serum 20S proteasome levels are associated with disease activity in MPO-ANCA-associated microscopic polyangiitis
by: Hiroshi Maruyama, et al.
Published: (2020-08-01)

P-ANCA Senza Positività per Anticorpi Anti-Mieloperossidasi (ANTI-MPO): Associazioni Cliniche
by: G. Gregorini, et al.
Published: (1995-10-01)

P15 THE EFFECT OF PEPTIGYLARGININE DEIMINASE 4 INHIBITOR ON MPO-ANCA PRODUCTION IN MOUSE MODEL
by: Y. Kusunoki, et al.
Published: (2016-11-01)

An unusual presentation of propylthiouracil-induced anti-MPO and PR3 positive ANCA vasculitis with associated anti-GBM antibodies, IgA nephropathy and an IgG4 interstitial infiltrate: a case report
by: Galante, JR, et al.
Published: (2020)

An unusual presentation of propylthiouracil-induced anti-MPO and PR3 positive ANCA vasculitis with associated anti-GBM antibodies, IgA nephropathy and an IgG4 interstitial infiltrate: a case report
by: J. R. Galante, et al.
Published: (2020-07-01)

Rapidly progressive glomerulonephritis secondary to anti-GBM disease associated with MPO-ANCA: a case report
by: Mariana Isaza-Meza, et al.
Published: (2023-03-01)

Clinical Significance of MPO-ANCA in Eosinophilic Granulomatosis With Polyangiitis: Experience From a Longitudinal Chinese Cohort
by: Suying Liu, et al.
Published: (2022-06-01)

Enho Mutations Causing Low Adropin: A Possible Pathomechanism of MPO-ANCA Associated Lung Injury
by: Feng Gao, et al.
Published: (2016-07-01)

COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab
by: Cinthia Baldallo, et al.
Published: (2021-05-01)

Implication of platelets and complement C3 as link between innate immunity and tubulointerstitial injury in renal vasculitis with MPO-ANCA seropositivity
by: Eva Baier, et al.
Published: (2022-11-01)

Altered circulating CCR6+and CXCR3+ T cell subsets are associated with poor renal prognosis in MPO-ANCA-associated vasculitis
by: Zhonghua Liao, et al.
Published: (2021-07-01)

Anti-Inflammatory and/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review
by: Hideaki Yamakawa, et al.
Published: (2022-07-01)

MPO–ANCA-Positive Granulomatosis with Polyangiitis with Rapidly Progressive Glomerulonephritis and Saddle-Nose Deformity: A Case Report
by: Dimitra Petrou, et al.
Published: (2022-05-01)

Rituximab in relapsing and de novo MPO ANCA-associated vasculitis with severe renal involvement: a case series
by: L. Caroti, et al.
Published: (2019-05-01)

Case report: A pediatric case of MPO-ANCA-associated granulomatosis with polyangiitis superimposed on post-streptococcal acute glomerulonephritis
by: Qianhuining Kuang, et al.
Published: (2023-07-01)

Fibrosis in atrial fibrillation – role of reactive species and MPO
by: Kai eFriedrichs, et al.
Published: (2012-06-01)

The potential pathogenic roles of S100A8/A9 and S100A12 in patients with MPO-ANCA-positive vasculitis
by: Xue Bai, et al.
Published: (2022-09-01)

The Roles of Neutrophil-Derived Myeloperoxidase (MPO) in Diseases: The New Progress
by: Wei Lin, et al.
Published: (2024-01-01)

The Enzymatic and Non-Enzymatic Function of Myeloperoxidase (MPO) in Inflammatory Communication
by: Yulia Kargapolova, et al.
Published: (2021-04-01)

Anti-hLAMP2-antibodies and dual positivity for anti-GBM and MPO-ANCA in a patient with relapsing pulmonary-renal syndrome
by: Kistler Thomas, et al.
Published: (2011-06-01)

MPO Expression of Background Neutrophils in MPO Negative Acute Promyelocytic Leukemia, An Easy Clue to Corroborate a Challenging Diagnosis: A Case Report and Review of Literature
by: Kritika Krishnamurthy, et al.
Published: (2023-01-01)

Effect of Sphingomyelinase-Treated LDLs on HUVECs
by: Angelica Giuliani, et al.
Published: (2023-02-01)